| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | fibroblast growth factor receptor activity | 1.57e-06 | 5 | 109 | 3 | GO:0005007 | |
| GeneOntologyMolecularFunction | fibroblast growth factor binding | 1.34e-05 | 27 | 109 | 4 | GO:0017134 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.81e-05 | 65 | 109 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.02e-04 | 85 | 109 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.16e-04 | 156 | 109 | 6 | GO:0019838 | |
| GeneOntologyMolecularFunction | ferric-chelate reductase (NADPH) activity | 2.92e-04 | 5 | 109 | 2 | GO:0052851 | |
| GeneOntologyMolecularFunction | ferric-chelate reductase activity | 2.92e-04 | 5 | 109 | 2 | GO:0000293 | |
| GeneOntologyMolecularFunction | cupric reductase (NADH) activity | 2.92e-04 | 5 | 109 | 2 | GO:0008823 | |
| GeneOntologyMolecularFunction | cholesterol transfer activity | 2.95e-04 | 24 | 109 | 3 | GO:0120020 | |
| GeneOntologyMolecularFunction | sterol transfer activity | 3.33e-04 | 25 | 109 | 3 | GO:0120015 | |
| GeneOntologyMolecularFunction | transporter activity | TPTE ABCA2 XKR9 RASA3 CETP TRPC1 GRAMD1A SLC44A2 GRIA4 XKR4 SLC3A2 SLC25A32 SCN10A TRPV2 SV2C SLC35F2 GRAMD1C | 6.04e-04 | 1289 | 109 | 17 | GO:0005215 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor | 6.09e-04 | 7 | 109 | 2 | GO:0016723 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 7.26e-04 | 196 | 109 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.20e-03 | 145 | 109 | 5 | GO:0004713 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 1.26e-03 | 386 | 109 | 8 | GO:0042578 | |
| GeneOntologyMolecularFunction | NAD(P)H oxidase H2O2-forming activity | 1.88e-03 | 12 | 109 | 2 | GO:0016174 | |
| GeneOntologyBiologicalProcess | regulation of neuron differentiation | RELN BRINP1 NOX1 ASPM BRINP2 FGFR1 FGFR3 NEUROG2 NEUROG3 CNTN2 WDR62 | 9.97e-08 | 255 | 108 | 11 | GO:0045664 |
| GeneOntologyBiologicalProcess | axon ensheathment in central nervous system | 7.57e-07 | 33 | 108 | 5 | GO:0032291 | |
| GeneOntologyBiologicalProcess | central nervous system myelination | 7.57e-07 | 33 | 108 | 5 | GO:0022010 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway | 2.76e-06 | 6 | 108 | 3 | GO:0090080 | |
| GeneOntologyBiologicalProcess | oligodendrocyte development | 1.43e-05 | 59 | 108 | 5 | GO:0014003 | |
| GeneOntologyBiologicalProcess | neuron migration | 1.95e-05 | 218 | 108 | 8 | GO:0001764 | |
| GeneOntologyBiologicalProcess | forebrain development | RELN RRM1 NRP2 ASPM ULK4 FGFR1 FGFR3 NEUROG2 NEUROG3 CNTN2 WDR62 | 5.18e-05 | 489 | 108 | 11 | GO:0030900 |
| GeneOntologyBiologicalProcess | oligodendrocyte differentiation | 8.45e-05 | 137 | 108 | 6 | GO:0048709 | |
| GeneOntologyBiologicalProcess | neutrophil extravasation | 1.08e-04 | 18 | 108 | 3 | GO:0072672 | |
| GeneOntologyBiologicalProcess | central nervous system development | ERBB2 RELN ABCA2 BRINP1 RRM1 NRP2 ASPM BRINP2 ULK4 SNTG2 FGFR1 FGFR3 NEUROG2 MYRF NEUROG3 CNTN2 WDR62 | 1.57e-04 | 1197 | 108 | 17 | GO:0007417 |
| GeneOntologyBiologicalProcess | alveolar secondary septum development | 1.62e-04 | 4 | 108 | 2 | GO:0061144 | |
| GeneOntologyBiologicalProcess | positive regulation of parathyroid hormone secretion | 1.62e-04 | 4 | 108 | 2 | GO:2000830 | |
| GeneOntologyBiologicalProcess | central nervous system neuron development | 1.73e-04 | 99 | 108 | 5 | GO:0021954 | |
| GeneOntologyBiologicalProcess | glial cell development | 1.78e-04 | 157 | 108 | 6 | GO:0021782 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 2.61e-04 | 24 | 108 | 3 | GO:0048015 | |
| GeneOntologyBiologicalProcess | iron ion import across cell outer membrane | 2.69e-04 | 5 | 108 | 2 | GO:0098706 | |
| GeneOntologyBiologicalProcess | regulation of parathyroid hormone secretion | 2.69e-04 | 5 | 108 | 2 | GO:2000828 | |
| HumanPheno | Cloverleaf skull | 1.49e-05 | 8 | 34 | 3 | HP:0002676 | |
| MousePheno | abnormal neuronal precursor cell number | 1.14e-05 | 52 | 80 | 5 | MP:0004979 | |
| MousePheno | abnormal sensory neuron innervation pattern | 1.40e-05 | 92 | 80 | 6 | MP:0000968 | |
| MousePheno | decreased neuronal precursor cell number | 5.69e-05 | 37 | 80 | 4 | MP:0004981 | |
| MousePheno | long incisors | 9.58e-05 | 16 | 80 | 3 | MP:0004831 | |
| MousePheno | macrodontia | 9.58e-05 | 16 | 80 | 3 | MP:0030091 | |
| MousePheno | increased hair follicle number | 9.67e-05 | 3 | 80 | 2 | MP:0012110 | |
| MousePheno | abnormal cell motility | TPTE ERBB2 RELN DNAH10 NRP2 NOX1 PIK3CG ASPM TRPV2 FGFR1 PLCG2 FUT7 NEUROG2 WDR62 BRWD1 | 1.28e-04 | 885 | 80 | 15 | MP:0020846 |
| Domain | FGF_rcpt_fam | 7.70e-07 | 4 | 109 | 3 | IPR016248 | |
| Domain | C2_dom | 5.33e-06 | 164 | 109 | 8 | IPR000008 | |
| Domain | - | 2.58e-05 | 148 | 109 | 7 | 2.60.40.150 | |
| Domain | Ferric_reduct | 4.09e-05 | 12 | 109 | 3 | PF01794 | |
| Domain | Fe3_Rdtase_TM_dom | 4.09e-05 | 12 | 109 | 3 | IPR013130 | |
| Domain | BRINP | 1.01e-04 | 3 | 109 | 2 | IPR033237 | |
| Domain | DUF4782 | 1.01e-04 | 3 | 109 | 2 | IPR031968 | |
| Domain | VAST | 1.01e-04 | 3 | 109 | 2 | PS51778 | |
| Domain | DUF4782 | 1.01e-04 | 3 | 109 | 2 | PF16016 | |
| Domain | C2 | 1.85e-04 | 142 | 109 | 6 | PS50004 | |
| Domain | ConA-like_dom | 3.00e-04 | 219 | 109 | 7 | IPR013320 | |
| Domain | Longin | 3.34e-04 | 5 | 109 | 2 | PF13774 | |
| Domain | - | 3.34e-04 | 5 | 109 | 2 | 3.30.450.50 | |
| Domain | Longin | 3.34e-04 | 5 | 109 | 2 | SM01270 | |
| Domain | Longin_dom | 3.34e-04 | 5 | 109 | 2 | IPR010908 | |
| Domain | LONGIN | 3.34e-04 | 5 | 109 | 2 | PS50859 | |
| Domain | HECT | 5.11e-04 | 27 | 109 | 3 | PF00632 | |
| Domain | HECTc | 5.11e-04 | 27 | 109 | 3 | SM00119 | |
| Domain | HECT_dom | 5.11e-04 | 27 | 109 | 3 | IPR000569 | |
| Domain | HECT | 5.11e-04 | 27 | 109 | 3 | PS50237 | |
| Domain | C2 | 1.03e-03 | 131 | 109 | 5 | PF00168 | |
| Domain | PH | 1.23e-03 | 278 | 109 | 7 | SM00233 | |
| Domain | C2 | 1.25e-03 | 137 | 109 | 5 | SM00239 | |
| Domain | PH_DOMAIN | 1.25e-03 | 279 | 109 | 7 | PS50003 | |
| Domain | PH_domain | 1.28e-03 | 280 | 109 | 7 | IPR001849 | |
| Domain | MAC_perforin | 1.47e-03 | 10 | 109 | 2 | IPR001862 | |
| Domain | Tyr_kinase_cat_dom | 1.76e-03 | 88 | 109 | 4 | IPR020635 | |
| Domain | TyrKc | 1.76e-03 | 88 | 109 | 4 | SM00219 | |
| Domain | TRP_channel | 1.79e-03 | 11 | 109 | 2 | IPR004729 | |
| Domain | XK-related | 1.79e-03 | 11 | 109 | 2 | PF09815 | |
| Domain | MACPF | 1.79e-03 | 11 | 109 | 2 | PF01823 | |
| Domain | XK_rel | 1.79e-03 | 11 | 109 | 2 | IPR018629 | |
| Domain | MACPF | 2.14e-03 | 12 | 109 | 2 | IPR020864 | |
| Domain | MACPF | 2.14e-03 | 12 | 109 | 2 | SM00457 | |
| Domain | PH | 2.26e-03 | 229 | 109 | 6 | PF00169 | |
| Domain | PROTEIN_KINASE_TYR | 2.51e-03 | 97 | 109 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.51e-03 | 97 | 109 | 4 | IPR008266 | |
| Domain | WW | 2.60e-03 | 47 | 109 | 3 | PF00397 | |
| Domain | WW | 2.76e-03 | 48 | 109 | 3 | SM00456 | |
| Domain | Ig-like_fold | PAPPA2 SEMA4B COL12A1 MMP23B PTPRU CD1D BTN1A1 FGFR1 FGFR3 FGFR4 CNTN2 | 2.78e-03 | 706 | 109 | 11 | IPR013783 |
| Domain | WW_DOMAIN_1 | 3.29e-03 | 51 | 109 | 3 | PS01159 | |
| Domain | WW_DOMAIN_2 | 3.29e-03 | 51 | 109 | 3 | PS50020 | |
| Domain | WW_dom | 3.47e-03 | 52 | 109 | 3 | IPR001202 | |
| Domain | GRAM | 3.84e-03 | 16 | 109 | 2 | SM00568 | |
| Domain | MAM | 4.33e-03 | 17 | 109 | 2 | SM00137 | |
| Domain | Ion_trans_dom | 4.48e-03 | 114 | 109 | 4 | IPR005821 | |
| Domain | Ion_trans | 4.48e-03 | 114 | 109 | 4 | PF00520 | |
| Domain | Laminin_G | 4.73e-03 | 58 | 109 | 3 | IPR001791 | |
| Domain | MAM | 4.86e-03 | 18 | 109 | 2 | PF00629 | |
| Domain | MAM_dom | 4.86e-03 | 18 | 109 | 2 | IPR000998 | |
| Domain | MAM_2 | 4.86e-03 | 18 | 109 | 2 | PS50060 | |
| Domain | - | PAPPA2 COL12A1 MMP23B PTPRU CD1D BTN1A1 FGFR1 FGFR3 FGFR4 CNTN2 | 5.40e-03 | 663 | 109 | 10 | 2.60.40.10 |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 1.00e-05 | 25 | 78 | 4 | M47934 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 1.28e-05 | 55 | 78 | 5 | M47952 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 3.73e-05 | 113 | 78 | 6 | MM14783 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 4.76e-05 | 118 | 78 | 6 | M713 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 5.45e-05 | 74 | 78 | 5 | M39857 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 7.52e-05 | 41 | 78 | 4 | MM14505 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER | 9.44e-05 | 83 | 78 | 5 | M27163 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 1.29e-04 | 47 | 78 | 4 | MM14885 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 1.40e-04 | 48 | 78 | 4 | M26916 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 1.40e-04 | 48 | 78 | 4 | MM15441 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 2.22e-04 | 54 | 78 | 4 | M27168 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 2.22e-04 | 54 | 78 | 4 | M620 | |
| Pathway | REACTOME_PI3K_AKT_SIGNALING_IN_CANCER | 3.54e-04 | 110 | 78 | 5 | M27162 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | 4.03e-04 | 63 | 78 | 4 | M635 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 4.81e-04 | 252 | 78 | 7 | MM15585 | |
| Pathway | REACTOME_NRCAM_INTERACTIONS | 6.23e-04 | 7 | 78 | 2 | M27378 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY | 6.55e-04 | 31 | 78 | 3 | M47396 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 8.23e-04 | 76 | 78 | 4 | MM15442 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR | 8.64e-04 | 77 | 78 | 4 | MM14722 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 9.37e-04 | 367 | 78 | 8 | M48346 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 9.39e-04 | 35 | 78 | 3 | M47379 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 1.09e-03 | 82 | 78 | 4 | M1021 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 1.14e-03 | 83 | 78 | 4 | M39637 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 1.14e-03 | 83 | 78 | 4 | M47961 | |
| Pubmed | 4.72e-10 | 5 | 110 | 4 | 28094278 | ||
| Pubmed | 1.41e-09 | 6 | 110 | 4 | 18753255 | ||
| Pubmed | Regulation of fibroblast growth factor-23 signaling by klotho. | 1.41e-09 | 6 | 110 | 4 | 16436388 | |
| Pubmed | 1.41e-09 | 6 | 110 | 4 | 19966287 | ||
| Pubmed | 1.41e-09 | 6 | 110 | 4 | 29720668 | ||
| Pubmed | FGF15 promotes neurogenesis and opposes FGF8 function during neocortical development. | 1.46e-08 | 25 | 110 | 5 | 18625063 | |
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 9212826 | ||
| Pubmed | FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer. | 1.23e-07 | 4 | 110 | 3 | 36142417 | |
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 11759058 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 12644244 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 9664689 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 27154171 | ||
| Pubmed | Immunolocalization of fibroblast growth factor receptors in normal and wounded human skin. | 1.23e-07 | 4 | 110 | 3 | 12373339 | |
| Pubmed | The FGF system has a key role in regulating vascular integrity. | 1.23e-07 | 4 | 110 | 3 | 18776942 | |
| Pubmed | RNAi-based conditional gene knockdown in mice using a U6 promoter driven vector. | 1.23e-07 | 4 | 110 | 3 | 17304337 | |
| Pubmed | 1.67e-07 | 16 | 110 | 4 | 24470103 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SEMA4B ERBB2 ABCA2 COL12A1 GOLM2 GRAMD1A PTDSS1 EXTL3 RRM1 SLC3A2 NRP2 NXPE3 FAT1 TENM3 FGFR4 ARHGAP21 WDR62 | 2.36e-07 | 1201 | 110 | 17 | 35696571 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | SEMA4B ERBB2 VPS39 GOLM2 WWP2 EXTL3 NRP2 FAT1 MROH1 C15orf61 FGFR1 STEAP1B RAB2A PIP4P2 MYRF CUX1 | 2.40e-07 | 1061 | 110 | 16 | 33845483 |
| Pubmed | 2.80e-07 | 18 | 110 | 4 | 27320921 | ||
| Pubmed | Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference. | 3.06e-07 | 5 | 110 | 3 | 15987787 | |
| Pubmed | The expression profiles of fibroblast growth factor 9 and its receptors in developing mice testes. | 3.06e-07 | 5 | 110 | 3 | 27078042 | |
| Pubmed | Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors. | 3.06e-07 | 5 | 110 | 3 | 16091423 | |
| Pubmed | FGF-dependent regulation of VEGF receptor 2 expression in mice. | 3.06e-07 | 5 | 110 | 3 | 21633168 | |
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 31758962 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 27206683 | ||
| Pubmed | Expression of fibroblast growth factor receptors in peri-implantation mouse embryos. | 3.06e-07 | 5 | 110 | 3 | 9771645 | |
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 9013630 | ||
| Pubmed | The mouse Fgfrl1 gene coding for a novel FGF receptor-like protein. | 3.06e-07 | 5 | 110 | 3 | 11566361 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA4B ERBB2 ABCA2 RASA3 VPS39 KHNYN EXTL3 FAT1 MROH1 ZBED4 PLEKHM2 ULK4 FGFR1 HERC2 MYRF ARHGAP21 | 4.11e-07 | 1105 | 110 | 16 | 35748872 |
| Pubmed | 5.44e-07 | 21 | 110 | 4 | 10579907 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 10572038 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 19515808 | ||
| Pubmed | Evidence that the novel receptor FGFRL1 signals indirectly via FGFR1. | 6.11e-07 | 6 | 110 | 3 | 24026051 | |
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 9010207 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 16365308 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 19232523 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 18231572 | ||
| Pubmed | FGF signaling expands embryonic cortical surface area by regulating Notch-dependent neurogenesis. | 6.63e-07 | 22 | 110 | 4 | 22031906 | |
| Pubmed | Expression patterns of FGF receptors in the developing mammalian cochlea. | 1.07e-06 | 7 | 110 | 3 | 20131355 | |
| Pubmed | 1.07e-06 | 7 | 110 | 3 | 16772167 | ||
| Pubmed | 1.07e-06 | 7 | 110 | 3 | 8959336 | ||
| Pubmed | 1.70e-06 | 8 | 110 | 3 | 18187602 | ||
| Pubmed | 1.70e-06 | 8 | 110 | 3 | 17623664 | ||
| Pubmed | ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner. | 1.70e-06 | 8 | 110 | 3 | 11940572 | |
| Pubmed | Syndecan-4 dependent FGF stimulation of mouse vibrissae growth. | 1.70e-06 | 8 | 110 | 3 | 16989989 | |
| Pubmed | 2.12e-06 | 29 | 110 | 4 | 21876757 | ||
| Pubmed | NPAS1 represses the generation of specific subtypes of cortical interneurons. | 2.12e-06 | 29 | 110 | 4 | 25467980 | |
| Pubmed | Expression of Fgf receptors 1, 2, and 3 in the developing mid- and hindbrain of the mouse. | 2.55e-06 | 9 | 110 | 3 | 15830353 | |
| Pubmed | Dynamic activation of Wnt, Fgf, and Hh signaling during soft palate development. | 2.55e-06 | 9 | 110 | 3 | 31613912 | |
| Pubmed | Integration of FGF and TWIST in calvarial bone and suture development. | 2.55e-06 | 9 | 110 | 3 | 10751173 | |
| Pubmed | 2.55e-06 | 9 | 110 | 3 | 11335076 | ||
| Pubmed | 2.55e-06 | 9 | 110 | 3 | 15229180 | ||
| Pubmed | 3.16e-06 | 126 | 110 | 6 | 16284245 | ||
| Pubmed | 3.63e-06 | 10 | 110 | 3 | 16193498 | ||
| Pubmed | 3.63e-06 | 10 | 110 | 3 | 15470137 | ||
| Pubmed | Regulation of external genitalia development by concerted actions of FGF ligands and FGF receptors. | 3.63e-06 | 10 | 110 | 3 | 15340846 | |
| Pubmed | 4.60e-06 | 35 | 110 | 4 | 20943929 | ||
| Pubmed | 4.98e-06 | 210 | 110 | 7 | 16537572 | ||
| Pubmed | Fgf20 is required for sensory epithelial specification in the developing cochlea. | 4.99e-06 | 11 | 110 | 3 | 18524904 | |
| Pubmed | 4.99e-06 | 11 | 110 | 3 | 20170731 | ||
| Pubmed | 4.99e-06 | 11 | 110 | 3 | 8901049 | ||
| Pubmed | 4.99e-06 | 11 | 110 | 3 | 26906157 | ||
| Pubmed | The murine gene, Traube, is essential for the growth of preimplantation embryos. | 4.99e-06 | 11 | 110 | 3 | 11071758 | |
| Pubmed | Immunohistochemical study of genesis of the mouse oral vestibule. | 6.63e-06 | 12 | 110 | 3 | 14964469 | |
| Pubmed | 6.63e-06 | 12 | 110 | 3 | 10751172 | ||
| Pubmed | Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4. | 6.63e-06 | 12 | 110 | 3 | 10918587 | |
| Pubmed | 6.63e-06 | 12 | 110 | 3 | 12460940 | ||
| Pubmed | The roles of FGF signaling in germ cell migration in the mouse. | 6.63e-06 | 12 | 110 | 3 | 16291796 | |
| Pubmed | 7.93e-06 | 40 | 110 | 4 | 30898150 | ||
| Pubmed | Testis Determination Requires a Specific FGFR2 Isoform to Repress FOXL2. | 8.60e-06 | 13 | 110 | 3 | 28938467 | |
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 9385055 | ||
| Pubmed | A point mutation in Fgf9 impedes joint interzone formation leading to multiple synostoses syndrome. | 8.60e-06 | 13 | 110 | 3 | 28169396 | |
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 8883961 | ||
| Pubmed | Receptor specificity of the fibroblast growth factor family. | 8.60e-06 | 13 | 110 | 3 | 8663044 | |
| Pubmed | 9.66e-06 | 42 | 110 | 4 | 23863479 | ||
| Pubmed | Molecular cloning and characterization of a novel human Rab ( Rab2B) gene. | 9.91e-06 | 2 | 110 | 2 | 12376746 | |
| Pubmed | Clathrin- and dynamin-independent endocytosis of FGFR3--implications for signalling. | 9.91e-06 | 2 | 110 | 2 | 21779335 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 29299828 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 16685373 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 20068287 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 27784895 | ||
| Pubmed | Oncogene mutation profiling reveals poor prognosis associated with FGFR1/3 mutation in liposarcoma. | 9.91e-06 | 2 | 110 | 2 | 27237367 | |
| Pubmed | Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. | 9.91e-06 | 2 | 110 | 2 | 1379594 | |
| Pubmed | FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. | 9.91e-06 | 2 | 110 | 2 | 9716527 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 20093646 | ||
| Pubmed | FGFR4 does not contribute to progression of chronic kidney disease. | 9.91e-06 | 2 | 110 | 2 | 31575945 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 28063257 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 17957151 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 34956100 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 11585811 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 28125801 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 20686451 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 18480409 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 29654068 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 36811310 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 34673637 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 26801869 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 37209327 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 23468956 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 19890272 | ||
| Interaction | FGF23 interactions | 5.17e-08 | 8 | 107 | 4 | int:FGF23 | |
| Interaction | KLB interactions | 3.60e-07 | 12 | 107 | 4 | int:KLB | |
| Interaction | KL interactions | 7.22e-07 | 14 | 107 | 4 | int:KL | |
| Interaction | GRAMD2B interactions | 2.79e-06 | 42 | 107 | 5 | int:GRAMD2B | |
| Interaction | FGF6 interactions | 5.01e-06 | 7 | 107 | 3 | int:FGF6 | |
| Interaction | FGF18 interactions | 5.01e-06 | 7 | 107 | 3 | int:FGF18 | |
| Interaction | FGF5 interactions | 7.99e-06 | 8 | 107 | 3 | int:FGF5 | |
| Interaction | FGF7 interactions | 7.75e-05 | 16 | 107 | 3 | int:FGF7 | |
| Interaction | FGF9 interactions | 7.75e-05 | 16 | 107 | 3 | int:FGF9 | |
| Interaction | GARIN4 interactions | 8.35e-05 | 3 | 107 | 2 | int:GARIN4 | |
| Interaction | FGF17 interactions | 8.66e-05 | 44 | 107 | 4 | int:FGF17 | |
| GeneFamily | C2 and WW domain containing | 1.15e-04 | 4 | 80 | 2 | 838 | |
| GeneFamily | Proteases, serine|STEAP family | 1.92e-04 | 5 | 80 | 2 | 1324 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 7.32e-04 | 40 | 80 | 3 | 321 | |
| GeneFamily | Blood group antigens|XK related family | 1.04e-03 | 11 | 80 | 2 | 955 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 1.46e-03 | 13 | 80 | 2 | 1146 | |
| GeneFamily | SNAREs|BCL2 homology region 3 (BH3) only | 1.96e-03 | 15 | 80 | 2 | 1124 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.20e-03 | 206 | 80 | 5 | 682 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.84e-03 | 21 | 80 | 2 | 813 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.67e-03 | 161 | 80 | 4 | 593 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOMTN | RELN TMEM169 GRIA4 XKR4 NRP2 TENM3 TRPV2 BRINP2 SV2C PIP4P2 CNTN2 | 7.66e-07 | 389 | 110 | 11 | M39073 |
| Coexpression | PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6 | 6.43e-06 | 29 | 110 | 4 | M2412 | |
| Coexpression | GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN | 2.22e-05 | 200 | 110 | 7 | M4108 | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 3.81e-07 | 184 | 110 | 7 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 3.81e-07 | 184 | 110 | 7 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.44e-07 | 194 | 110 | 7 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.03e-07 | 197 | 110 | 7 | a07ab2564ca7d577fd47f444dd7b0c25556e9fc4 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 5.37e-06 | 178 | 110 | 6 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.54e-06 | 179 | 110 | 6 | 1c0c0647a111f691dae55f4ed8c51006059ce020 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.10e-06 | 182 | 110 | 6 | 0e52ba34e179d9bfaac7b49920b44c710b2b8dad | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.49e-06 | 184 | 110 | 6 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.49e-06 | 184 | 110 | 6 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 6.49e-06 | 184 | 110 | 6 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.49e-06 | 184 | 110 | 6 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.49e-06 | 184 | 110 | 6 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD79a_B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-06 | 187 | 110 | 6 | b51af2824e65734f333b1325117f4a2e88b17c23 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-06 | 187 | 110 | 6 | 3ca3954f45f167e98a230f2847f0582d74fcd32e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.53e-06 | 193 | 110 | 6 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.78e-06 | 194 | 110 | 6 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.04e-06 | 195 | 110 | 6 | 1e28617ca55e5f318a228357737b968dfac8cca0 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.31e-06 | 196 | 110 | 6 | b6226163d9fc93ecfff2115bb74408303a000490 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.31e-06 | 196 | 110 | 6 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.58e-06 | 197 | 110 | 6 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.58e-06 | 197 | 110 | 6 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.04e-05 | 200 | 110 | 6 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-05 | 200 | 110 | 6 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-05 | 200 | 110 | 6 | 091a18d6efed81cab99955c3047f172170f70476 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.04e-05 | 200 | 110 | 6 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-05 | 200 | 110 | 6 | 3b8513defe25262ab4b492345b2628570eaefd17 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Macroglial-Glia_progenitor_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-05 | 200 | 110 | 6 | 0b91c8da21ba488109f15c9b927c1dcaf8c6b0ae | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.04e-05 | 200 | 110 | 6 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.04e-05 | 200 | 110 | 6 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.04e-05 | 200 | 110 | 6 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.04e-05 | 200 | 110 | 6 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Spon1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.60e-05 | 127 | 110 | 5 | cd69ba386796715e87674f8324d2acaad1d4d094 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-05 | 132 | 110 | 5 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-05 | 154 | 110 | 5 | 5ed64bbf603290e6dc34f81d145982690b89dd0d | |
| ToppCell | Control-Endothelial-Epi-like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.42e-05 | 157 | 110 | 5 | 4d02c50d5d1b892ea241e98724386d8a5a156a46 | |
| ToppCell | Control-Endothelial-Epi-like-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.42e-05 | 157 | 110 | 5 | 2c369660c752c0fb3bd798a561d3359e2f9aa983 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_naive|lymph-node_spleen / Manually curated celltypes from each tissue | 4.56e-05 | 158 | 110 | 5 | 7098847804dd90fa1dd74536e4e90f989b630fe4 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 158 | 110 | 5 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 158 | 110 | 5 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-05 | 161 | 110 | 5 | fb59d96c2aa9e4654f02bf6ce36bf832776cb4dd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-05 | 161 | 110 | 5 | c53c461fc721a7960cef86662f49e2a495520701 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.13e-05 | 162 | 110 | 5 | 2ac02523348660e514d464f8f2434ee0c312d784 | |
| ToppCell | Healthy_Control-Lymphoid-B-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.29e-05 | 163 | 110 | 5 | d84bd41b4494c7d5c7f88d511bfe481fb12f079d | |
| ToppCell | Control-APC-like-Monocytes|Control / group, cell type (main and fine annotations) | 5.29e-05 | 163 | 110 | 5 | 4bc80a2c741d462724b6f3902377d48c57478932 | |
| ToppCell | Healthy_Control-Lymphoid-B|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.29e-05 | 163 | 110 | 5 | 0f723ec2503afa1b3ebb0754972438ffb6e6179d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-05 | 164 | 110 | 5 | a784f47f67a5eda84d58ad7d9400e3978edbb487 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-05 | 164 | 110 | 5 | 1a1795969673232191425dde84ab24ee6a98143f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-05 | 164 | 110 | 5 | 8f074940afdbda88a4b697a7ddc687e09a4b818b | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.44e-05 | 164 | 110 | 5 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 5.93e-05 | 167 | 110 | 5 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | mild-Lymphocytic-B_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.93e-05 | 167 | 110 | 5 | 0811f7559c2a7151693771e52e14af3978997118 | |
| ToppCell | COVID-19-Heart-Adipocyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.27e-05 | 169 | 110 | 5 | bd39f85b48207955f80ca120a11e15a0124117b9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-05 | 170 | 110 | 5 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-05 | 170 | 110 | 5 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-05 | 170 | 110 | 5 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.45e-05 | 170 | 110 | 5 | 4848965bc7e9356c6601bb41eeea1553d2eea87e | |
| ToppCell | CD8+_Memory_T_cell-FLU-3|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.82e-05 | 172 | 110 | 5 | 45ac433dbb3796f69e886c04457b2971403050ee | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-05 | 173 | 110 | 5 | 25d72fa7a84baf5660ead6da67327590f5c91860 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 7.20e-05 | 174 | 110 | 5 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.40e-05 | 175 | 110 | 5 | 87e557f7508c88b2087db5d57e77d5e2c92ca083 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 7.60e-05 | 176 | 110 | 5 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 7.60e-05 | 176 | 110 | 5 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.60e-05 | 176 | 110 | 5 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 177 | 110 | 5 | c274fbdc141855ff4581d437d4997c64cc193278 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.81e-05 | 177 | 110 | 5 | f10f77130dbb2c0ad1b436ceb4fb1deac2b0267c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 177 | 110 | 5 | f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.81e-05 | 177 | 110 | 5 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.81e-05 | 177 | 110 | 5 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 177 | 110 | 5 | c8a51e480b978dc0ded85583261f2c892e085be8 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.23e-05 | 179 | 110 | 5 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.23e-05 | 179 | 110 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.23e-05 | 179 | 110 | 5 | 06d412fc096d88de168969466ce422f0ab5553b2 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.23e-05 | 179 | 110 | 5 | dfd5b25f2a6a5a8bf4714f1516cb0997de72b06f | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.23e-05 | 179 | 110 | 5 | df4d0b2fe47d2c7def729b3217cb01ced01495ff | |
| ToppCell | COVID-19_Moderate-B_intermediate|World / disease group, cell group and cell class | 8.45e-05 | 180 | 110 | 5 | bd81b87a6dc81e5ab4a6c948eb0c80f14401a6a7 | |
| ToppCell | MatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4) | 8.45e-05 | 180 | 110 | 5 | adc64ad6033af705dd7b9163a83e20ef5c59f6eb | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.67e-05 | 181 | 110 | 5 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.67e-05 | 181 | 110 | 5 | 6df40f86c569b6ecfc3137a68d1355b012dbf6bf | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.67e-05 | 181 | 110 | 5 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 183 | 110 | 5 | ed1e0b07475f9951728682ed70b85367cf2a744d | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 9.13e-05 | 183 | 110 | 5 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.13e-05 | 183 | 110 | 5 | 93213124e55d1b673dd345188caf8b5bd31d99fe | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 9.13e-05 | 183 | 110 | 5 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.37e-05 | 184 | 110 | 5 | f6d6b3ddada66dae28d3306415bf4efe0934208a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-05 | 184 | 110 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 9.37e-05 | 184 | 110 | 5 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-05 | 184 | 110 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-05 | 184 | 110 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.37e-05 | 184 | 110 | 5 | 3b0389c3a5a16697de860e98ebc48ed39ede646f | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 9.37e-05 | 184 | 110 | 5 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.61e-05 | 185 | 110 | 5 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.61e-05 | 185 | 110 | 5 | eb338fcda0b237c2e0b9b4b0daf51febbfe1d79c | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.61e-05 | 185 | 110 | 5 | c31bb53852caf36964b83b28bcaee07b679da779 | |
| ToppCell | 18-Distal-Epithelial-Epithelial|Distal / Age, Tissue, Lineage and Cell class | 9.61e-05 | 185 | 110 | 5 | d2a266724f3f70f746a78034f308d98f8b7a66e3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.61e-05 | 185 | 110 | 5 | 1d731d69d8db8aef4a11439b8abd1030c7e6ac4c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.61e-05 | 185 | 110 | 5 | b8d02c9426740ffcb69d2e6f95473b388149d297 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.61e-05 | 185 | 110 | 5 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.84e-05 | 97 | 110 | 4 | 2cd5cafdf0a9a468baaafd4613d790fc048ee53e | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Coch_(Coch)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.84e-05 | 97 | 110 | 4 | adda7a49b7754ed110e212346768bf52107c26fc | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Coch_(Coch)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.84e-05 | 97 | 110 | 4 | 6d865ec3a413f595de17e0a5f8c61666ebb3e252 | |
| Drug | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea | 4.37e-07 | 4 | 110 | 3 | ctd:C568950 | |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 5.16e-07 | 198 | 110 | 9 | 4529_UP | |
| Drug | Palifermin | 2.17e-06 | 6 | 110 | 3 | DB00039 | |
| Drug | Flucytosine [2022-85-7]; Down 200; 31uM; MCF7; HT_HG-U133A | 4.52e-06 | 193 | 110 | 8 | 5289_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; PC3; HT_HG-U133A | 4.52e-06 | 193 | 110 | 8 | 6699_DN | |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Up 200; 15uM; HL60; HT_HG-U133A | 5.45e-06 | 198 | 110 | 8 | 2496_UP | |
| Drug | nitrobenzyl-DOTA | 2.41e-05 | 35 | 110 | 4 | CID000129949 | |
| Disease | bone disease (implicated_via_orthology) | 4.61e-07 | 5 | 107 | 3 | DOID:0080001 (implicated_via_orthology) | |
| Disease | oral squamous cell carcinoma (is_implicated_in) | 3.13e-06 | 28 | 107 | 4 | DOID:0050866 (is_implicated_in) | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 1.65e-05 | 42 | 107 | 4 | EFO_0004286, EFO_0004629 | |
| Disease | high grade glioma (implicated_via_orthology) | 1.98e-05 | 44 | 107 | 4 | DOID:3070 (implicated_via_orthology) | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 5.88e-05 | 21 | 107 | 3 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | TWIST1-related craniosynostosis | 7.78e-05 | 4 | 107 | 2 | cv:C4551902 | |
| Disease | stomach cancer (is_marker_for) | 1.72e-04 | 142 | 107 | 5 | DOID:10534 (is_marker_for) | |
| Disease | Head and Neck Neoplasms | 2.34e-04 | 33 | 107 | 3 | C0018671 | |
| Disease | Craniosynostosis syndrome | 2.70e-04 | 7 | 107 | 2 | cv:C0010278 | |
| Disease | venous thromboembolism | 2.78e-04 | 460 | 107 | 8 | EFO_0004286 | |
| Disease | protein FAM177A1 measurement | 3.60e-04 | 8 | 107 | 2 | EFO_0801948 | |
| Disease | circulating alpha-Klotho measurement | 3.60e-04 | 8 | 107 | 2 | EFO_0020102 | |
| Disease | kynurenine measurement | 3.85e-04 | 39 | 107 | 3 | EFO_0008529 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 4.47e-04 | 41 | 107 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 4.47e-04 | 41 | 107 | 3 | C0858252 | |
| Disease | Malignant Head and Neck Neoplasm | 5.51e-04 | 44 | 107 | 3 | C0278996 | |
| Disease | Asthma, Occupational | 5.75e-04 | 10 | 107 | 2 | C0264423 | |
| Disease | level of Phosphatidylcholine (O-18:2_16:0) in blood serum | 5.75e-04 | 10 | 107 | 2 | OBA_2045132 | |
| Disease | Head and Neck Carcinoma | 5.75e-04 | 10 | 107 | 2 | C3887461 | |
| Disease | glucagon-like peptide-1 measurement | 5.75e-04 | 10 | 107 | 2 | EFO_0008465 | |
| Disease | Pathological accumulation of air in tissues | 8.40e-04 | 12 | 107 | 2 | C0013990 | |
| Disease | mood disorder | 9.90e-04 | 13 | 107 | 2 | EFO_0004247 | |
| Disease | Carcinogenesis | 9.90e-04 | 13 | 107 | 2 | C0596263 | |
| Disease | Autosomal recessive primary microcephaly | 1.33e-03 | 15 | 107 | 2 | cv:C3711387 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:4) in blood serum | 1.33e-03 | 15 | 107 | 2 | OBA_2045131 | |
| Disease | lysophosphatidylcholine measurement | 1.50e-03 | 62 | 107 | 3 | EFO_0010224 | |
| Disease | gliosarcoma | 1.51e-03 | 16 | 107 | 2 | C0206726 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 1.51e-03 | 16 | 107 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | waist-hip ratio | PAPPA2 XKR9 DNAH10 WWP2 ZDHHC12 PPP2R5A PDE8B FGFR1 FGFR4 ARHGAP21 CUX1 CNTN2 | 1.64e-03 | 1226 | 107 | 12 | EFO_0004343 |
| Disease | FEV/FEC ratio | XKR9 VPS13C BRINP1 FAM83B NRP2 WWC2 ULK4 FGFR1 FGFR3 FGFR4 CUX1 CNTN2 | 1.66e-03 | 1228 | 107 | 12 | EFO_0004713 |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.67e-03 | 139 | 107 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Brachycephaly | 1.71e-03 | 17 | 107 | 2 | C0221356 | |
| Disease | stem Cell Factor measurement | 1.88e-03 | 67 | 107 | 3 | EFO_0008291 | |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 2.14e-03 | 19 | 107 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 2.62e-03 | 21 | 107 | 2 | EFO_0004286, EFO_0004792 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 2.62e-03 | 21 | 107 | 2 | OBA_2045083 | |
| Disease | Autosomal Recessive Primary Microcephaly | 2.87e-03 | 22 | 107 | 2 | C3711387 | |
| Disease | Primary microcephaly | 2.87e-03 | 22 | 107 | 2 | C0431350 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 3.14e-03 | 23 | 107 | 2 | EFO_0004286, EFO_0004791 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 3.39e-03 | 169 | 107 | 4 | DOID:3908 (is_marker_for) | |
| Disease | Neoplasm of the genitourinary tract | 3.41e-03 | 24 | 107 | 2 | cv:C0042065 | |
| Disease | stomach carcinoma (is_marker_for) | 3.41e-03 | 24 | 107 | 2 | DOID:5517 (is_marker_for) | |
| Disease | Giant Cell Glioblastoma | 3.57e-03 | 84 | 107 | 3 | C0334588 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VERTSYNGHLTIWFT | 71 | Q9NYP8 | |
| RRRFTHQSDVWSYGV | 896 | P04626 | |
| FYSNIFRWETTISIA | 111 | Q8IYS0 | |
| RMLYFWFSERVFHSL | 276 | P11597 | |
| HLWTNYTTRAFIFLS | 531 | Q5SY80 | |
| NRWKTFFETVHIYLR | 606 | O60477 | |
| TIGSIFFTWRLYNER | 261 | Q13410 | |
| STVINWFHNYRSRIR | 1286 | P39880 | |
| LFDRVYTHQSDVWSF | 661 | P22455 | |
| RAAITLQHYFRTWQT | 2861 | Q8IZT6 | |
| YRLWSLERTAHTFES | 631 | Q96CP6 | |
| QYVWHTSSGENLFRI | 1381 | Q9ULI1 | |
| YDITRRDTFNHLTTW | 86 | P61019 | |
| YDITRRETFNHLTSW | 86 | Q8WUD1 | |
| RWFRLTNHEFTYHKS | 601 | Q14644 | |
| RTVTQFHFLSWYDRG | 901 | Q92932 | |
| SSAWSTVFRHVRYEN | 11 | Q9H2D1 | |
| GRIFYVDHVNRTTTW | 821 | Q9P2P5 | |
| SATEFIRRSYFEVFW | 191 | Q9Y5S8 | |
| RLDRESTSHYWLTVF | 1096 | Q14517 | |
| VVAFDVYNHRWRSLT | 336 | Q8N239 | |
| IETLRFAHNYIWALT | 151 | Q9H2A3 | |
| FAHNYIWALTETLRL | 156 | Q9H2A3 | |
| RFAHNYIWALTQTLR | 126 | Q9Y4Z2 | |
| ASTSWRHFAEVAYIV | 1111 | O95714 | |
| AGRFHTVLWTREAVY | 291 | Q9P2D0 | |
| LLNENFRREYWTIFH | 296 | Q13585 | |
| CEYFILRNIHTFEFW | 351 | Q8IY21 | |
| HTTKSFLRNWRIESY | 486 | Q5T0W9 | |
| VLFLVSRFSPYEWHT | 561 | P48058 | |
| TLRAWFQVIEANYHS | 596 | O95263 | |
| IFNWVLSYRRDSDIF | 136 | Q11130 | |
| LTWVFLALYFSRHQV | 6 | O60462 | |
| NDYTLSFWRSGRVQH | 571 | P16885 | |
| DFFTRVALYVDWIRS | 231 | P24158 | |
| VFEDYVHSSERRVSW | 696 | Q9H8H2 | |
| FSAYDVLFHQWLQSR | 221 | Q8NDA8 | |
| SIYHASEFTQWRRVI | 981 | P78509 | |
| VRHFQFLRWSAYRDT | 1336 | Q92729 | |
| EAFSRYNISWQLSVH | 556 | Q9BXP8 | |
| VTFSRIRYHEAVQRW | 401 | O15229 | |
| NIHISDEWYTRFRVS | 2121 | Q99715 | |
| WETLQHIFRVYRSSF | 81 | P15813 | |
| ALFDRIYTHQSDVWS | 671 | P11362 | |
| SRRFYHLANDNFIWI | 101 | Q8NCQ5 | |
| RNFTLTVTDFYRSWN | 591 | O43909 | |
| SVFRTVHTQGQWAYR | 726 | O95886 | |
| FDRLTVEEHLWFYSR | 1076 | Q9BZC7 | |
| FSYIRHWDQNERFLV | 551 | P08195 | |
| YLLSFRRQGSTHWQT | 746 | Q02246 | |
| VWEVRYIEHNARTFN | 1226 | Q9NSI6 | |
| FSWRYQLREFQSRFH | 111 | Q9H6B9 | |
| ELGVTHYRFSISWAR | 141 | Q9UEF7 | |
| VQYFWDRGHRDITVF | 466 | O15037 | |
| FQTDFRVYLHLRQTW | 301 | Q8IWA5 | |
| LFDRVYTHQSDVWSF | 666 | P22607 | |
| AIYWERSLFFRIKHT | 571 | Q8IVF4 | |
| YELRNLWQLFFHVTV | 271 | Q96IW7 | |
| STDFYHTQDFLEWRR | 21 | Q9BRL7 | |
| VAFTRRFNHVSFWVV | 91 | Q86X27 | |
| SSGYWVLVVHFTRRE | 61 | Q8IWE5 | |
| VYFISSWGDQTFRLH | 581 | Q2WGJ9 | |
| VVLAFNYWSISSRHV | 26 | Q6P4E1 | |
| RITAYNVWAVINHFS | 81 | P59540 | |
| GSAYQFHSWRVFVIV | 311 | Q496J9 | |
| VHLFGDSTIRQWFEY | 356 | Q969Y0 | |
| LRWDHFNLTYRILSF | 86 | O75900 | |
| YDSVFSVVRRHQFRW | 166 | Q8NFW8 | |
| FARRFRATYVSWAIA | 216 | Q8N4L2 | |
| RDTLFYGVFTSQWHR | 336 | Q9NPR2 | |
| FLSVHSSYQWELRLT | 371 | Q9BR26 | |
| RAVTVRYTFTEWRSF | 246 | B7ZBB8 | |
| VSTFDWVRAERTYHL | 336 | Q9NY99 | |
| LSWFILHARYRVIHF | 151 | Q8IXU6 | |
| VSDSLTWREFHYIQS | 241 | Q9UHE8 | |
| SVSDSLTWREFHYIQ | 221 | Q6NZ63 | |
| LGNRWKTFFETVHVY | 631 | Q9C0B6 | |
| SSSHFQVAERALYFW | 361 | Q15172 | |
| SWLFARVTETVHTSY | 126 | A6NNL5 | |
| FWFLRSEIAQSRHYQ | 696 | P48736 | |
| WYIFSLAHVAIFVTR | 596 | P48995 | |
| FWLHTSFIENNRLYL | 496 | P56180 | |
| FYYVDHNTRTTTWQR | 346 | O00308 | |
| VFYIDHNTRRTSWID | 26 | Q6AWC2 | |
| LSAFYNTHDLTRWEL | 706 | Q9UJ98 | |
| AIETYNLLSERWFTH | 186 | P23921 | |
| YRIVEHSWFESFIIF | 1146 | Q9Y5Y9 | |
| RRHVFIWISFIDSYF | 456 | Q9Y5S1 | |
| SLSVQVFSFRWFVHD | 156 | Q5GH76 | |
| VFERSPFLTQYHTVW | 916 | Q9P273 | |
| QLIWSVVRHYSEQFL | 3396 | Q709C8 | |
| TFCTYVAWIVFRRQH | 241 | Q96LQ0 | |
| SEYRWHINFTTFFID | 311 | O00767 | |
| HQFSSWESRIYAVAT | 416 | Q9ULM0 | |
| QSVDLIFTRLWIYSH | 181 | P57060 | |
| LDRALYWHFLTDTFT | 176 | Q68CL5 | |
| SYFVTVGNRHVRFWF | 211 | O43379 | |
| AFIRWLEEFTSQYSR | 91 | Q70CQ3 | |
| FDGRTFSVNSIIYRW | 606 | Q8WU66 | |
| LRVAARDLTWFQYHS | 476 | Q9BY64 | |
| TWEFISSHRIAYLRQ | 211 | Q96GR4 | |
| FLVYNEERTFWHKIS | 191 | Q96HH4 | |
| VSFSNHRTRSWDYIE | 486 | Q5T5U3 | |
| YFSRQWADTFIVSLH | 146 | A4D1P6 | |
| ITWERIISHFDIFAF | 156 | P48651 | |
| EIVVNNRITWLFHYS | 111 | Q8IZJ6 | |
| ILWYLFRHSTADSLR | 651 | Q96C45 | |
| LHLIFSYSVWVLRDF | 551 | Q96JC1 | |
| IWVSVRFFHEGQYVF | 26 | Q5GH70 | |
| REYLTLTAHWVSFES | 741 | O75132 | |
| VRLIQVYHISRNSWF | 446 | Q2WGJ6 | |
| WPITILSFREFTYHF | 1106 | Q9Y2G1 |